lanthanum has been researched along with Vascular Calcification in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 21 (75.00) | 24.3611 |
| 2020's | 7 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bu, R; Gao, J; Han, R; Hao, J; Li, B; Li, G; Liu, H; Liu, Y; Sun, L; Wang, S; Zhao, J; Zhao, L | 1 |
| An, M; Bu, R; Cao, X; Gao, J; Gao, Y; Gu, C; Guo, M; Han, R; Hao, J; Li, B; Li, G; Liu, H; Liu, Y; Meng, Y; Su, C; Sun, L | 1 |
| Akizawa, T; Fukagawa, M; Hirakata, H; Kagimura, T; Ogata, H | 1 |
| Badve, SV; Elder, GJ; Hawley, CM; Lioufas, NM; Pascoe, EM; Pedagogos, E; Toussaint, ND; Valks, A | 1 |
| Jiang, J; Li, Y; Liu, G; Wang, Z; Zheng, D; Zhou, H | 1 |
| Badve, SV; Block, GA; Boudville, N; Cameron, JD; Campbell, KL; Chen, SSM; Elder, GJ; Faull, RJ; Hawley, CM; Holt, SG; Hooi, LS; Jackson, D; Jardine, MJ; Johnson, DW; Kerr, PG; Lau, KK; Lioufas, NM; Narayan, O; Pascoe, EM; Pedagogos, E; Perkovic, V; Polkinghorne, KR; Pollock, CA; Reidlinger, D; Robison, L; Smith, ER; Toussaint, ND; Valks, A; Walker, RJ; Wang, AYM | 1 |
| Akizawa, T; Fukagawa, M; Fukushima, M; Hirakata, H; Kagimura, T; Ogata, H | 1 |
| Fujii, H; Goto, S; Kono, A; Kono, K; Nakai, K; Nishi, S; Nishii, T | 1 |
| Kinoshita, O; Motomura, N; Ono, M; Yamauchi, H | 1 |
| Gao, Y; Li, Y; Lv, C; Wang, G; Wang, Z | 1 |
| Braidotti, P; Brancaccio, D; Brenna, I; Ciceri, P; Cozzolino, M; Elli, F; Romagnoli, S; Tosi, D; Volpi, E | 1 |
| Guo, H; Tang, S; Zhang, S; Zhang, X | 1 |
| Elisaf, MS; Kalaitzidis, RG | 1 |
| Goumenos, DS; Papachristou, E; Sonikian, M | 1 |
| Chen, H; Liu, L; Wang, Y; Yang, Y; Zhou, L; Zhu, X | 1 |
| Sun, J; Wang, R; Yang, XW; Zhai, CJ | 1 |
| Kitazono, T; Noguchi, H; Ooboshi, H; Tatsumoto, N; Tokumoto, M; Tsuruya, K; Yamada, S | 1 |
| Hanafusa, N | 1 |
| Burnier, M; Funk, F; Maillard, M; Malluche, HH; Phan, O; Stehle, JC | 1 |
| Ding, GH; He, Y; Li, J; Li, MM; Liu, D; Mu, CJ; Peng, QP; Wang, XH; Yang, GS; Zhang, X | 1 |
| Garg, AX; Habbous, S; Martin, J | 1 |
| Kawashima, S; Minakuchi, J; Nagai, K; Tsuchida, K; Yokota, N | 1 |
| Benchitrit, J; Drüeke, TB; Edelman, A; Guerrera, IC; Joki, N; Jorgetti, V; Lacour, B; Machado dos Reis, L; Maizel, J; Massy, ZA; Nguyen-Khoa, T; Nikolov, IG | 1 |
| Akizawa, T; Mizobuchi, M; Nakazawa, A | 1 |
| Gou, BD; Wang, K; Zhang, TL; Zhao, WH | 1 |
| Borghi, E; Brancaccio, D; Brenna, I; Ciceri, P; Cozzolino, M; Elli, F; Volpi, E | 1 |
| Flanigan, M; Haynes, WG; Kalil, RS; Stanford, W | 1 |
| Allison, MA; Asplin, J; Block, GA; Chertow, GM; Hoofnagle, AN; Kestenbaum, B; Ketteler, M; Kooienga, L; Mannstadt, M; Persky, MS; Smits, G; Spiegel, DM; Thadhani, R; Wheeler, DC; Wolf, M | 1 |
6 review(s) available for lanthanum and Vascular Calcification
| Article | Year |
|---|---|
Effects and safety of lanthanum carbonate in end stage renal disease patients with hyperphosphatemia: a meta-analysis--system review of lanthanum carbonate.
Topics: Bone and Bones; Calcium; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Parathyroid Hormone; Phosphates; Vascular Calcification | 2013 |
Optimal use of phosphate binders in chronic kidney disease.
Topics: Aluminum Hydroxide; Calcium Compounds; Chelating Agents; Humans; Hyperphosphatemia; Lanthanum; Magnesium; Patient Compliance; Phosphates; Polyamines; Practice Guidelines as Topic; Renal Insufficiency, Chronic; Sevelamer; Vascular Calcification | 2013 |
The effects of non-calcium-based phosphate binders versus calcium-based phosphate binders on cardiovascular calcification and bone remodeling among dialysis patients: a meta-analysis of randomized trials.
Topics: Biomarkers; Bone Remodeling; Calcium; Calcium Phosphates; Cardiovascular Diseases; Chelating Agents; Humans; Lanthanum; Polyamines; Randomized Controlled Trials as Topic; Renal Dialysis; Sevelamer; Vascular Calcification | 2014 |
Efficacy and safety of lanthanum carbonate versus calcium-based phosphate binders in patients with chronic kidney disease: a systematic review and meta-analysis.
Topics: Bone Density; Calcium; Calcium Carbonate; Chelating Agents; Humans; Hypercalcemia; Lanthanum; Parathyroid Hormone; Phosphorus; Radiography; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Vascular Calcification | 2015 |
[Vascular Calcification - Pathological Mechanism and Clinical Application - . The effect of phosphate binders on vascular calcification].
Topics: Bone Diseases, Metabolic; Calcium; Cardiovascular Diseases; Chelating Agents; Drug Discovery; Humans; Hyperphosphatemia; Japan; Lanthanum; Polyamines; Prognosis; Renal Insufficiency, Chronic; Sevelamer; Vascular Calcification | 2015 |
[Bone and calcium update; diagnosis and therapy of metabolic bone disease update. Advances in treatment of CKD-MBD].
Topics: Bone Diseases, Metabolic; Chronic Disease; Cinacalcet; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Klotho Proteins; Lanthanum; Membrane Proteins; Naphthalenes; Vascular Calcification; Vitamin D | 2011 |
7 trial(s) available for lanthanum and Vascular Calcification
| Article | Year |
|---|---|
Effect of lanthanum carbonate and calcium carbonate on the progression of coronary artery calcification among hemodialysis patients with vascular calcification risk: a randomized controlled trial.
Topics: Calcium; Calcium Carbonate; Chelating Agents; Coronary Artery Disease; Humans; Hyperphosphatemia; Lanthanum; Phosphates; Renal Dialysis; Treatment Outcome; Vascular Calcification | 2022 |
Aortic Calcification and Arterial Stiffness Burden in a Chronic Kidney Disease Cohort with High Cardiovascular Risk: Baseline Characteristics of the Impact of Phosphate Reduction On Vascular End-Points in Chronic Kidney Disease Trial.
Topics: Age Factors; Aged; Aorta; Disease Progression; Female; Fibroblast Growth Factor-23; Glomerular Filtration Rate; Heart Disease Risk Factors; Humans; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphates; Pulse Wave Analysis; Sex Factors; Treatment Outcome; Vascular Calcification; Vascular Stiffness | 2020 |
A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD).
Topics: Aged; Aorta, Abdominal; Double-Blind Method; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; Humans; Hyperphosphatemia; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphates; Pulse Wave Analysis; Renal Insufficiency, Chronic; Tomography, X-Ray Computed; Vascular Calcification | 2020 |
Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial.
Topics: Aged; Calcium Carbonate; Cardiovascular Diseases; Female; Heart Disease Risk Factors; Hip Fractures; Humans; Hyperparathyroidism; Hyperphosphatemia; Incidence; Japan; Lanthanum; Male; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Survival Analysis; Vascular Calcification | 2021 |
Effects of oral activated charcoal on hyperphosphatemia and vascular calcification in Chinese patients with stage 3-4 chronic kidney disease.
Topics: Administration, Oral; Adult; Aged; Biomarkers; Calcium Carbonate; Charcoal; Chelating Agents; Female; Humans; Hyperphosphatemia; Lanthanum; Male; Middle Aged; Phosphates; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome; Vascular Calcification | 2019 |
Dissociation between progression of coronary artery calcification and endothelial function in hemodialysis patients: a prospective pilot study.
Topics: Aged; Biomarkers; Brachial Artery; Calcium; Chelating Agents; Chronic Disease; Coronary Artery Disease; Disease Progression; Endothelium, Vascular; Humans; Iowa; Kidney Diseases; Lanthanum; Middle Aged; Phosphorus; Pilot Projects; Polyamines; Prospective Studies; Renal Dialysis; Sevelamer; Time Factors; Treatment Outcome; Vascular Calcification; Vasodilation | 2012 |
Effects of phosphate binders in moderate CKD.
Topics: Acetates; Aged; Aged, 80 and over; Bone Density; Calcium Compounds; Chelating Agents; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphates; Pilot Projects; Polyamines; Renal Insufficiency, Chronic; Sevelamer; Vascular Calcification | 2012 |
15 other study(ies) available for lanthanum and Vascular Calcification
| Article | Year |
|---|---|
Lanthanum hydroxide inhibits vascular calcification by regulating the HIF-1 pathway.
Topics: Animals; Cardiovascular Diseases; Lanthanum; Phosphorus; Rats; Renal Insufficiency, Chronic; Vascular Calcification | 2022 |
Metabolomics of clinical samples reveal the treatment mechanism of lanthanum hydroxide on vascular calcification in chronic kidney disease.
Topics: Amino Acid Transport Systems, Neutral; Humans; Kidney Failure, Chronic; Lanthanum; Metabolomics; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Renal Insufficiency, Chronic; TOR Serine-Threonine Kinases; Vascular Calcification | 2022 |
Fortified phosphorus‑lowering treatment through administration of lanthanum protects against vascular calcification via regulation of FGF23 in chronic kidney disease.
Topics: Animals; Blood Urea Nitrogen; Calcium; Creatinine; Disease Models, Animal; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Kidney; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Protective Agents; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Vascular Calcification | 2020 |
Effects of Lanthanum Carbonate on Coronary Artery Calcification and Cardiac Abnormalities After Initiating Hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Calcium Carbonate; Chelating Agents; Coronary Vessels; Female; Fibroblast Growth Factor-23; Humans; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome; Vascular Calcification | 2018 |
Lanthanum carbonate, a phosphate binder, inhibits calcification of implanted aortic allografts in a rat model.
Topics: Allografts; Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Diseases; Blood Vessel Prosthesis; Calcium; Calcium Carbonate; Lanthanum; Male; Models, Animal; Phosphorus; Rats; Rats, Inbred BN; Rats, Inbred Lew; Transplantation, Homologous; Vascular Calcification | 2019 |
Lanthanum prevents high phosphate-induced vascular calcification by preserving vascular smooth muscle lineage markers.
Topics: Animals; Blotting, Western; Calcinosis; Cell Differentiation; Cell Lineage; Cells, Cultured; Gadolinium; Lanthanum; Male; Muscle, Smooth, Vascular; Osteoblasts; Phosphates; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Vascular Calcification | 2013 |
Hyperphosphatemia and phosphate binders: effectiveness and safety.
Topics: Calcium; Chelating Agents; Diet; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Hyperthyroidism; Lanthanum; Phosphates; Phosphorus, Dietary; Polyamines; Renal Dialysis; Renal Insufficiency; Sevelamer; Vascular Calcification | 2014 |
Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.
Topics: Adenine; Animal Feed; Animals; Calcinosis; Calcium Carbonate; Cellular Senescence; Disease Models, Animal; Disease Progression; Fibrosis; Immunohistochemistry; Inflammation; Kidney; Kidney Failure, Chronic; Lanthanum; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxidative Stress; Phosphates; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Signal Transduction; Uremia; Vascular Calcification | 2015 |
Effects of Sucroferric Oxyhydroxide Compared to Lanthanum Carbonate and Sevelamer Carbonate on Phosphate Homeostasis and Vascular Calcifications in a Rat Model of Chronic Kidney Failure.
Topics: Animals; Body Weight; Disease Models, Animal; Drug Combinations; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Homeostasis; Kidney Failure, Chronic; Lanthanum; Male; Mortality; Phosphates; Rats, Wistar; Sevelamer; Sucrose; Vascular Calcification | 2015 |
Effects of lanthanum carbonate on vascular calcification in elderly maintenance hemodialysis patients.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Female; Humans; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphates; Pruritus; Renal Dialysis; Treatment Outcome; Vascular Calcification | 2015 |
Appraisal of a redundant report on lanthanum carbonate.
Topics: Chelating Agents; Humans; Lanthanum; Renal Insufficiency, Chronic; Vascular Calcification | 2016 |
Impact of Lanthanum Carbonate on Prognosis of Chronic Hemodialysis Patients: A Retrospective Cohort Study (Kawashima Study).
Topics: Aged; Cardiovascular Diseases; Chelating Agents; Cohort Studies; Disease Progression; Female; Humans; Lanthanum; Male; Middle Aged; Phosphorus; Prognosis; Proportional Hazards Models; Renal Dialysis; Retrospective Studies; Treatment Outcome; Vascular Calcification | 2016 |
Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice.
Topics: Analysis of Variance; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Blood Chemical Analysis; Bone Density; Collagen; Disease Models, Animal; Disease Progression; Female; Immunohistochemistry; Lanthanum; Mice; Mice, Inbred Strains; Polyamines; Random Allocation; Reference Values; Renal Insufficiency, Chronic; Sevelamer; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Uremia; Vascular Calcification | 2012 |
Lanthanum chloride bidirectionally influences calcification in bovine vascular smooth muscle cells.
Topics: Alkaline Phosphatase; Animals; Apoptosis; Atherosclerosis; Calcium Phosphates; Caspases; Cattle; Cell Survival; Glycerophosphates; Humans; Kidney Failure, Chronic; Lanthanum; Membrane Potential, Mitochondrial; Microscopy, Electron, Scanning; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Particle Size; Receptors, Calcium-Sensing; Vascular Calcification | 2012 |
The combination of lanthanum chloride and the calcimimetic calindol delays the progression of vascular smooth muscle cells calcification.
Topics: Animals; Calcimimetic Agents; Calcium; Cells, Cultured; Indoles; Lanthanum; Muscle, Smooth, Vascular; Naphthalenes; Phosphates; Rats; Receptors, Calcium-Sensing; Vascular Calcification | 2012 |